国药控股(01099.HK)获Lazard Asset Management LLC增持1735.31万股

Group 1 - Lazard Asset Management LLC increased its stake in China National Pharmaceutical Group (国药控股) by purchasing 17,353,148 shares at an average price of HKD 20.8997 per share, totaling approximately HKD 363 million [1][2] - Following the acquisition, Lazard's total shareholding in China National Pharmaceutical Group rose to 176,585,924 shares, increasing its ownership percentage from 11.87% to 13.16% [1][2]